Zohydro
Product Images NDC 43376-350

8 FDA label images from Zogenix, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Zohydro (NDC 43376-350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zogenix, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Hydrocodone Bitartrate. (Zohydro Extended Release Capsules 1)

The Structural Formula For Hydrocodone Bitartrate. (Zohydro Extended Release Capsules 1)
Chemical structure diagram of the active ingredient in Zohydro. The image shows molecular formulas and structural formulas including carbon, hydrogen, oxygen, and nitrogen atoms, along with associated groups and molecular weight information (MW = 494.50).*
FDA Label Image

Figure (Zohydro Extended Release Capsules 2)

Figure (Zohydro Extended Release Capsules 2)
A line graph depicting percentage improvement in average pain intensity from screening to final visit. The x-axis shows percent improvement in pain from screening ranging from 10% to 100%, and the y-axis shows the percentage of subjects improved from 0% to 100%. Two lines compare Zohydro ER and placebo, with Zohydro ER showing a higher percentage of subjects with pain improvement at each level compared to placebo.*
FDA Label Image

Ndc 43376-310-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 10 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 3)

Ndc 43376-310-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 10 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 3)
Label for Zohydro ER extended-release capsules containing hydrocodone bitartrate 10 mg. The label instructs to swallow capsules whole and not to chew, crush, or dissolve. It states the package contains 60 capsules and is prescription only. The label includes storage instructions and manufacturer information for Zogenix, Inc.*
FDA Label Image

Ndc 43376-315-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 15 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 4)

Ndc 43376-315-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 15 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 4)
Zohydro ER 15 mg extended-release capsules label containing hydrocodone bitartrate. The package includes 60 capsules for prescription use only, with instructions to swallow capsules whole without chewing, crushing, or dissolving. The label also highlights a new formulation and provides storage and dosage details, along with the manufacturer Zogenix, Inc. information.*
FDA Label Image

Ndc 43376-320-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 20 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 5)

Ndc 43376-320-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 20 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 5)
Label for Zohydro ER extended-release capsules containing 20 mg hydrocodone bitartrate. The label indicates the product is a prescription medication supplied as 60 capsules with instructions to swallow whole. It includes storage instructions, dosage warnings, and identifies Zogenix, Inc. as the manufacturer.*
FDA Label Image

Ndc 43376-330-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 30 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 6)

Ndc 43376-330-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 30 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 6)
Label for Zohydro ER extended-release capsules containing 30 mg hydrocodone bitartrate. The label indicates a package size of 60 capsules, with instructions to swallow capsules whole and not to chew, crush, or dissolve. It includes storage information and a notice of a new formulation. The label shows the NDC 43376-330-60, manufactured by Akorn-Catalent, and is for prescription use only by Zogenix, Inc.*
FDA Label Image

Ndc 43376-340-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 40 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 7)

Ndc 43376-340-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 40 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 7)
Zohydro ER 40 mg extended-release capsules label showing hydrocodone bitartrate as the active ingredient. The label indicates 60 capsules per container and includes directions to swallow capsules whole without chewing, crushing, or dissolving. It also notes the new formulation and storage instructions. The product is labeled by Zogenix, Inc.*
FDA Label Image

Ndc 43376-350-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 50 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 8)

Ndc 43376-350-60 Zohydro Er (hydrocodone Bitartrate) Extended-release Capsules 50 mg 60 Capsules Rx Only (Zohydro Extended Release Capsules 8)
Zohydro ER 50 mg extended-release capsules label showing hydrocodone bitartrate as the active ingredient. The label indicates storage instructions, dosage cautions, and packaging details including capsule count of 60. Manufactured by Akema's Gainesville, LLC and labeled by Zogenix Inc. Contains warnings to swallow capsules whole and not to chew or crush.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.